GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

1,558.20p
   
  • Change Today:
    -17.80p
  • 52 Week High: 1,625.00
  • 52 Week Low: 1,242.80
  • Currency: UK Pounds
  • Shares Issued: 4,959.87m
  • Volume: 6,419,066
  • Market Cap: £77,285m
  • RiskGrade: 82
  • Beta: 0.00

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (16-07-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.1% 5.1%
Div Cover 1.4 1.4
Op Mrgn 13.5% 24.9%
ROCE n/a  
Latest F'cast
P/E 13.9 14.4
PEG 1.5 n/a
Pr/Revenue 2.6 2.6
Pr/Book 22.2  
Latest F'cast
Revenue 8.2% -0.8%
PBT 81.8% 111.3%
EPS 9.2% -3.3%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 29,942.15 7,447.37 108.10p 14.4 n/a -3% 80.00p 5.1%
31-Dec-19 30,636.37 7,586.61 112.67p 13.8 3.3 +4% 80.13p 5.1%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 16-Jul-2018 14:51 RNS
Director/PDMR Shareholding 16-Jul-2018 11:11 RNS
Director/PDMR Shareholding 13-Jul-2018 16:16 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
13-Jul-18 Buy Dividends David Redfern 1,586.50p 23 £364.89
13-Jul-18 Buy Dividends Victoria Whyte 1,586.50p 19 £301.43
12-Jul-18 Buy Dividends David Redfern 1,570.91p 1,838 £28,873.33

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,558.20p
Change Today -17.80p
% Change -1.13 %
52 Week High 1,625.00
52 Week Low 1,242.80
Volume 6,419,066
Shares Issued 4,959.87m
Market Cap £77,285m
Beta 0.00
RiskGrade 82

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average
30.16% above the sector average30.16% above the sector average30.16% above the sector average30.16% above the sector average30.16% above the sector average
Price Trend
1.1% below the market average1.1% below the market average1.1% below the market average1.1% below the market average1.1% below the market average
17.46% above the sector average17.46% above the sector average17.46% above the sector average17.46% above the sector average17.46% above the sector average
Income
71.35% above the market average71.35% above the market average71.35% above the market average71.35% above the market average71.35% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Growth
33.14% above the market average33.14% above the market average33.14% above the market average33.14% above the market average33.14% above the market average
19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average

What The Brokers Say

Strong Buy 12
Buy 2
Neutral 12
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 10-May-18 22-Feb-18
Paid 12-Jul-18 12-Apr-18
Amount 19.00p 23.00p

Trades for 16-Jul-2018

Time Volume / Share Price
16:53 600 @ 1,547.80p
16:52 2,963 @ 1,550.40p
16:52 2,190 @ 1,553.30p
16:52 175 @ 1,559.43p
16:52 1,616 @ 1,563.51p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley

Top of Page